Anjali Vaidya, MD, FACC, FASE, FACP, Director of the Advanced Pulmonary Hypertension, Right Heart Failure & Chronic Thromboembolic Pulmonary Hypertension Program at Temple University Hospital, participated in a Q&A interview with Healio about pulmonary arterial hypertension (PAH). The series of six videos covered topics including the importance of early recognition/diagnosis, the potential of targeted treatments and era of innovation, and the use of technology. Dr. Vaidya specifically discussed the virtual echocardiography screening tool (VEST), which when incorporated into the electronic medical record (EMR) system, can generate accurate PAH risk scores – without the need for time-consuming manual calculations. The novel approach is the first of its kind in the field of pulmonary vascular medicine and was developed by Dr. Vaidya and physicians at the Lewis Katz School of Medicine at Temple University.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH